Ketamine Pretreatment Exacerbated 3,4-Methylenedioxymethamphetamine-Induced Central Dopamine Toxicity

Jing-Jer Ke；Ming-Che Ho；Chian-Fang G. Cherng；Yen-Ping N. Tsai；Chia-Wen Tsai；Lung Yu

ecstasy ； serotonin ； dopamine ； anesthetic ； DAT ； VMAT-2

The Chinese Journal of Physiology

51卷2期（2008 / 04 / 01）

65 - 70

英文

Currently, joint use of ketamine and 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy) represents a specific combination of polydrug abuse. Long-lasting and even aggravated central neuronal toxicity associated with mixing ketamine and MDMA use is of especially concern. This study was undertaken to examine the modulating effects of ketamine treatment on later MDMA-induced dopamine and serotonin neurotoxicity. We found that repeated administration of ketamine (50mg/kg×7) at 1.5-h intervals did not render observable dopamine or serotonin depletion in catecholaminergic target regions examined. In contrast, three consecutive doses of MDMA (20mg/kg each) at 2-h intervals produced long-lasting dopamine and serotonin depletions in striatum, nucleus accumbens and prefrontal cortex. More importantly, pretreatment with binge doses of ketamine (50mg/kg×7 at 1.5-h intervals) 12 h prior to the MDMA dosing regimen (20mg/kg×3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity. Nonetheless, such binge doses of ketamine treatment did not affect MDMA induced serotonergic toxicity. These results, taken together, indicate that binge use of ketamine specifically enhances the MDMA-induced central dopaminergic neurotoxicity in adult mouse brain.

1. Armstrong, B.D.,Noguchi, K.K.(2004).The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.Neurotoxicology,25,905-914.
2. Callahan, B.T.,Cord, B.J.,Yuan, J.,McCann, U.D.,Ricaurte, G.A.(2001).Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity.J. Neurochem.,77,1348-1362.
3. Darvesh, A.S.,Gudelsky, G.A.(2005).Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.Brain Res.,1056,168-175.
4. Farfel, G.M.,Seiden L.S.(1995).Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.J. Pharm. Exper. Ther.,272,860-867.
5. Finnegan, K.T.,Taraska, T.(1996).Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.J. Neurochem.,66,1949-1958.
6. Galineau, L.,Belzung, C.,Kodas, E.,Bodard, S.,Guilloteau, D.,Chalon, S.(2005).Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.Brain Res. Dev. Brain Res.,154,165-176.
7. Goni-Allo, B.,Puerta, E.,Hervias, I.,Di Palma, R.,Ramos, M.,Lasheras, B.,Aguirre, N.(2007).Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamineinduced serotonin depletion in rats.Eur. J. Pharmacol.,562,198-207.
8. Goni-Allo, B.,Ramos, M.,Hervas, I.,Lasheras, B.,Aguirre, N.(2006).Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/ dopamine interactions.J. Psychopharmacol.,20,245-256.
9. Hansen, J.P.,Riddle, E.L.,Sandoval, V.,Brown, J.M.,Gibb, J.W.,Hanson, G.R.,Fleckenstein, A.E.(2002).Methylenedioxymetham-phetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.J. Pharmacol. Exp. Ther.,300,1093-1100.
10. Hayashi, H.,Dikkes, P.,Soriano, S.G.(2002).Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain.Ped. Anaes.,12,770-774.
11. Kelly, B.C.,Parsons, J.T.,Wells, B.E.(2006).Prevalence and predictors of club drug use among club-going young adults in New York city.J. Urban Health,83,884-895.
12. Koprich, J.B.,Campbell, N.G.,Lipton, J.W.(2003).Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.Brain Res. Dev. Brain Res.,147,177-182.
13. Martin, I.,Lampinen, T.M.,McGhee, D.(2006).Methamphetamine use among marginalized youth in British Columbia.Can. J. Public Health,97,320-324.
14. Moghaddan, B.,Adams, B.,Verma, A.,Daly, D.(1997).Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.J. Neurosci.,17,2921-2927.
15. Nishizawa, N.,Nakao, S.,Nagata, A.,Hirose, T.,Masuzawa, M.,Shingu, K.(2000).The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulated and retrosplenial cortices.Brain Res.,857,188-192.
16. Olney, J.W.(2002).New insights and new issues in developmental neurotoxicology.Neurotoxicol.,23,659-668.
17. Pu, C.,Vorhees, C.V.(1995).Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study.Synapse,19,97-104.
18. Scallet, A.C.,Schmued, L.C.,Slikker, W.,Grunberg, N.,Faustino, P.J.,Davis, H.,Lester, D.,Pine, P.S.,Sistare, F.,Hanig, J.P.(2004).Developmental neurotoxicity of ketamine: Morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons.Toxic. Sci.,81,364-370.
19. Schensul, J.J.,Convey, M.,Burkholder, G.(2005).Challenges in measuring concurrency, agency and intentionality in polydrug research.Addict. Behav.,30,571-574.
20. Sharp, F.R.,Jasper, P.,Hall, J.,Noble, L.,Sagar, S.M.(1991).MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex.Ann. Neurol.,30,801-809.
21. Slikker, W.,Xu, Z.,Wang, C.(2005).Application of a systems biology approach to developmental neurotoxicology.Reprod. Toxicol.,19,305-319.
22. Sonsalla, P.K.,Nicklas, W.J.,Heikkila, R.E.(1989).Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science,243,398-400.
23. Wu, L.T.,Schlenger, W.E.,Galvin, D.M.(2006).Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.Drug Alcohol Depend.,84,102-113.
24. Zhang, L.,Shirayama, Y.,Shimizu, E.,Iyo, M.,Hashimoto, K.(2006).Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.Eur. J. Pharmacol.,544,1-9.